Fig. 2From: Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degenerationSummary of selected protocols for hiPSC-derived RPE transplant studies using chemical moleculesBack to article page